Skip to main content
SpringerLink
Log in

A Review of the Efficacy of Adenine Arabinoside and Lymphoblastoid Interferon in the Royal Free Hospital Studies of Hepatitis B Virus Carrier Treatment: Identification of Factors Influencing Response Rates

  • Conference paper
Book cover Viral Hepatitis

Part of the book series: Proceedings in Life Sciences ((LIFE SCIENCES))

  • 68 Accesses

Abstract

Many anti-viral agents have been tried in the treatment of chronic HBV infection (Pollard et al. 1978; Weller et al. 1982, 1983; Greenberg et al. 1976; Lok et al. 1984a; Smith et al. 1983). Only adenine arabinoside in both its native and monophosphate forms and the alpha interferons have been evaluated to a level where comments on clinical usefulness can be made.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abb J, Zachoval R, Einsenburg J, Pape GR, Zachoral ‘V, Deinhardt F (1985) Production of alpha interferon and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J Med Virol 16: 171–176

    CAS  Google Scholar 

  • Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlok S (1981) Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology 80: 1016–1022

    PubMed  CAS  Google Scholar 

  • Eddleston AWLF, Mondelli M, Mieli-Vergani G, Williams R (1982) Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. Hepatology 2: 1225–1275

    Google Scholar 

  • Friedman RL, Stark GR (1985) Interferon induced transcription of HLA and metallothione in genes containing homologous upstream sequence. Nature 314: 637–639

    Article  PubMed  CAS  Google Scholar 

  • Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC (1976) Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 295: 517–522

    Article  PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones AE (1984) Randomised controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology 86: 150–157

    PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Hanson RG, Minuk GY, Pappas SC, Schafer DF, Dusheiko GM, Straus SE, Popper H, Jones AE (1984) Randomised controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology 86: 150–157

    PubMed  CAS  Google Scholar 

  • Iwarson S, Tabor E, Thomas HC, Snoy P, Gerety RJ (1985) Protection against hepatitis B virus infection by immunisation with hepatitis B core antigen. Gastroenterology 88: 763–767

    PubMed  CAS  Google Scholar 

  • Iwarson S, Thomas HC. Passive immunisation with anti-HBc in hepatitis B. (in preparation)

    Google Scholar 

  • Kato Y, Nakagawa H, Kobayashi K, Hattori N, Hatano K (1982) Interferon production by peripheral lymphocytes in HBsAg-positive liver disease. Hepatology 2: 789–790

    Article  PubMed  CAS  Google Scholar 

  • Levin S, Hahn T (1985) Interferon deficiency syndrome. Clin Exp Immunol 60: 267–273

    PubMed  CAS  Google Scholar 

  • Lok ASF, Wilson LA, Thomas HC (1984) Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection. J Antimicrob Chemother 14: 93–99

    Article  PubMed  CAS  Google Scholar 

  • Lok ASF, Weller IVD, Karayannis P, Brown D, Fowler MJF, Monjardino J, Thomas HC, Sherlok S (1984) Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver 4: 45–49

    PubMed  CAS  Google Scholar 

  • Lok ASF, Weller IVD, Karayannis P, Brown D, Fowler MJF, Monjardino J, Thomas HC, Sherlok S (1984) Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver 4: 45–49

    PubMed  CAS  Google Scholar 

  • Novick DM, Lok ASF, Thomas HC (1984) Diminshed responsiveness of homosexual men to antiviral therapy for HBsAg positive chronic liver disease. J Hepatology 1: 29–35

    Article  Google Scholar 

  • Novick DM, Lok ASF, Thomas HC (1984) Diminshed responsiveness of homosexual men to antiviral therapy for HBsAg positive chronic liver disease. J Hepatology 1: 29–35

    Article  Google Scholar 

  • Perillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC (1985) Comparative efficacy of adenine arabinoside 5’-monophosphate and prednisone withdrawal followed by adenine arabinoside 5 ’-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 88: 780–786

    Google Scholar 

  • Perillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC (1985) Comparative efficacy of adenine arabinoside 5’-monophosphate and prednisone withdrawal followed by adenine arabinoside 5 ’-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 88: 780–786

    Google Scholar 

  • Perillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC (1985) Comparative efficacy of adenine arabinoside 5’-monophosphate and prednisone withdrawal followed by adenine arabinoside 5 ’-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 88: 780–786

    Google Scholar 

  • Pollard RB, Smith JL, Neal A, Gregory PB, Merigan TC, Robinson WS (1978) The effect of vidarabine on chronic hepatitis B infection. J Am Med Assoc 239: 1648–1650

    Article  CAS  Google Scholar 

  • Realdi G, Alberti A, Rugge M, Bortolotti F, Rigoli AM, Tremolada F, Ruol A (1980) Seroconversion from hepatitis Be antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 79: 195–199

    PubMed  CAS  Google Scholar 

  • Regenstein FG, Roodman ST, Perillo RP (1983) Immunoregulatory T-cell subsets in chronic hepatitis B virus infection: The influence of homosexuality. Hepatology 31: 951–954

    Google Scholar 

  • Sacks SL. Scullard GH, Pollard RB, Gregory PB, Robinson WS, Merigan TC (1982). Antiviral treatment of chronic hepatitis B virus infection: pharmokinetics and side effect of interferon and adenine arabinoside alone and in combination. Antimicrob Agents Chemother 21: 91–100

    Google Scholar 

  • Schalm SW, Heijtink RA (1982) Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg positive chronic active hepatitis: results of a placebo vs interferon trial. Hepatology 2: 791–794

    Article  PubMed  CAS  Google Scholar 

  • Scullard GH, Pollard RB, Smith JL, Sacks SL. Gregory PB, Robinson WS, Merigan TC (1981) Antiviral treatment of chronic hepatitis B virus infection. 1. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis 143: 772–783

    Google Scholar 

  • Scully LJ, Shein R, Karayiannis P, Thomas HC. Lymphoblastoid interferon therapy of chronic hepatitis B virus infection: a randomised trial of 12 weeks vs 24 weeks of treatment (in preparation)

    Google Scholar 

  • Smith CI, Weissberg J, Bernhardt L, Gregory PB, Robinson WS, Merigan TC (1983) Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection. J Infect Dis 148: 907–913

    Article  PubMed  CAS  Google Scholar 

  • Thomas HC, Shipton U, Montano L (1982) The HLA system: its relevance to the pathogenesis of liver disease. In: Popper H, Schaffner F (eds) Progress in liver disease, vol VI. Grune & Stratton, New York, pp 517–527

    Google Scholar 

  • Thomas HC, Shipton U, Montano L (1982) The HLA system: its relevance to the pathogenesis of liver disease. In: Popper H, Schaffner F (eds) Progress in liver disease, vol VI. Grune & Stratton, New York, pp 517–527

    Google Scholar 

  • Thomas HC, Lever AML, Scully LJ, Pignatelli M (1986) Approaches to the treatment of HBV and delta related liver disease. Semin Liver Dis 6: 34–41

    Article  PubMed  CAS  Google Scholar 

  • Thomas HC, Pignatelli M, Lever AML (1986) Homology between HBV-DNA and a sequence of regulating the interferon antiviral system: a possible mechanism of persistent infection. J Med Virol 19: 63–69

    Article  PubMed  CAS  Google Scholar 

  • Trepo C, Hantz O, Ouzan D, Chossegros P, Chevalier P, Berthillon P, Brette R (1984) Therapeutic efficacy of ARA-AMP in symptomatic HBeAg-positive CAH: a randomised placebo control study. Hepatology 4: 1055

    Google Scholar 

  • Viola LA, Barrison IG, Coleman JC, Paradinas FJ, Fluker JL, Murray-Lyon IM (1981) Natural history of liver disease in chronic hepatitis B surface antigen carriers: a survey of 100 patients from Great Britain. Lancet 2: 1156–1159

    Article  PubMed  CAS  Google Scholar 

  • Yokosuka O, Ornata M, Imazeki F, Hirota K, Mori J, Uchiumi K, Ito Y, Okuda K (1985) Combination of short term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. Gastroenterology 89: 246–251

    PubMed  CAS  Google Scholar 

  • Weller IVD, Bassendine MF, Craxi A, Fowler MJF, Monjardino J, Thomas HC, Sherlock S (1982) Successful treatment of HBs and HBeAg-positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5’-monophosphate ( ARA-AMP ). Gut 23: 717–723

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Carreno V, Fowler MJF, Monjardino J, Makinen D, Varghese Z, Sweny P, Thomas HC, Sherlock S (1983) Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with IV bolus administration. J Antimicrob Chemother 11: 223–231

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Lok ASF, Mindel A, Karayiannis P, Sarah Galphin, Monjardino J, Sherlock S, Thomas HC (1985) A randomised controlled trial of adenine arabinoside 5’-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Gut 26: 745–751

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Department of Medicine, Royal Free Hospital and School of Medicine, Pond Street, Hampstead, London, NW3 2QG, UK

    M. Pignatelli

Authors
  1. H. C. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. J. Scully
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. L. Lever
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Yap
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Pignatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Histochemistry Unit, 1st Department of Pathology Spedali Civili of Brescia, Aggregaat Hoger Onderwijs, Catholic University of Leuven, 25100, Brescia, Italy

    Francesco Callea

  2. 1st Department of Pathology, Spedali Civili of Brescia, 25100, Brescia, Italy

    Mario Zorzi (Professor of Pathology and Chairman) (Professor of Pathology and Chairman)

  3. Laboratory of Histochemistry and Cytochemistry, Catholic University of Leuven, 3000, Leuven, Belgium

    Valeer J. Desmet (Professor of Pathology) (Professor of Pathology)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Thomas, H.C., Scully, L.J., Lever, A.M.L., Yap, I., Pignatelli, M. (1986). A Review of the Efficacy of Adenine Arabinoside and Lymphoblastoid Interferon in the Royal Free Hospital Studies of Hepatitis B Virus Carrier Treatment: Identification of Factors Influencing Response Rates. In: Callea, F., Zorzi, M., Desmet, V.J. (eds) Viral Hepatitis. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71350-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71350-7_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71352-1

  • Online ISBN: 978-3-642-71350-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation